SCN1A and Febrile seizure (within the age range of 3 months to 6 years): SCN1A mutations are associated with developmental and epileptic encephalopathy, Dravet syndrome, febrile seizures, and generalized epilepsy with febrile seizures plus (GEFS+) [18,19,20].